Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

RefleXion's co-founder and CTO, Sam Mazin, Ph.D. and Todd Powell, CEO and president. (Photo: Business Wire)
News | Radiation Therapy
RefleXion Receives FDA Clearance for SCINTIX Biology-Guided Radiotherapy

February 2, 2023 — RefleXion Medical, a therapeutic oncology company, today announced the U.S. Food and Drug ...

Time February 02, 2023
arrow
The V Foundation for Cancer Research has announced a new grant program aimed at increasing female representation and female-led innovation in cancer research.
News | Radiation Oncology
New Grant Program by the V Foundation Established to Boost Female-led Cancer Research

February 2, 2023 — The V Foundation, a top cancer research charity, has announced the establishment of a new grant ...

Time February 02, 2023
arrow
software for the treatment of cancer with radiotherapy
News | Radiation Therapy
Brazilian Startup Pioneers Cloud Software for Secondary Monitor Unit Calculation in Radiotherapy, Enhancing Patient Safety

February 1, 2023 — Radiotherapy is a crucial component of cancer treatment, used to shrink or destroy tumors with high ...

Time February 01, 2023
arrow
Top 10 content for the month of January 2023
Feature | Radiology Business | By Melinda Taschetta-Millane
Top 10: January's Most-read Content

Here is a recap of what ITN viewers found most interesting during the month of January: 1. A Look at the Changes in 2023 ...

Time February 01, 2023
arrow
Age-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new analysis of more than 500,000 patient records.
News | Radiation Therapy
Study Finds Large Gap in Breast Cancer Treatment Recommendations for Patients Aged 70 vs 69

January 31, 2023 — Age-based heuristics can lead to large differences in breast cancer treatment based on small ...

Time January 31, 2023
arrow
48-year-old woman who underwent CEM to evaluate two masses (arrows) in right breast. CEM obtained in following order: (A) craniocaudal (CC) view of right breast; (B) CC view of left breast; (C) mediolateral oblique (MLO) view of right breast; and (D) MLO view of left breast. Degree of background parenchymal enhancement (BPE) increases over time after contrast agent injection. (A) CC view of right breast shows mild BPE, whereas subsequently obtained (B) CC view of left breast shows moderate BPE.
News | Stereotactic Breast Imaging
Clinical Factors Associated With Early BPE on Contrast-Enhanced Mammography

January 27, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), both ...

Time January 27, 2023
arrow
Have you read the January/February 2023 issue of Imaging Technology News?
Feature | Radiology Imaging | By Melinda Taschetta-Millane
ITN's January/February Issue is Here!

Have you read the January/February 2023 issue of Imaging Technology News? If not, take some time out of your busy ...

Time January 24, 2023
arrow
Study finds that Black patients and patients living in certain regions experience greater delays.
News | Breast Imaging
Race and Geography Linked to Different Risks of Breast Cancer Treatment Delays

January 24, 2023 — For patients with cancer, lengthy delays in treatment can decrease their chances of survival. In an ...

Time January 24, 2023
arrow
Capturing more information from every slide, stain, and tissue sample than humanly possible, artificial intelligence is used to hone in on a set of 8-12 key features specific to each disease.
News | Artificial Intelligence
PreciseDx Announces Publication in Breast Cancer Research that Validates Its AI-Enabled Platform

January 23, 2023 — PreciseDx, a leading innovator in AI-powered, patient-specific disease analysis, announced its recent ...

Time January 23, 2023
arrow
How the imaging community is working to drive awareness and increase access to life-saving screening
Feature | Lung Imaging | By Christine Book
Special Report on Lung Cancer and Screening Initiatives, Part III

In this third in the three-part Special Report, the ITN editorial team offers the most current information on reported ...

Time January 17, 2023
arrow
This month, our One on One ... column features Kim L. Sandler, MD, who addresses the topic of lung cancer screening. The full video interview with Sandler can be found at www.itnonline.com/videos.
Feature | Lung Imaging | By Christine Book
One on One ... With Kim L. Sandler, MD

New for 2023, in each issue, Imaging Technology News (ITN) will profile a leader in radiology to share insight, updates ...

Time January 16, 2023
arrow
The Cancer Breakthroughs session of ASTRO2022 included research findings presented on behalf of the American Society of Clinical Oncology (ASCO) and the American Association of Physicists in Medicine (AAPM). Photo credit: ASTRO
Feature | ASTRO | Christine Book
ASTRO 2022 Shines Spotlight on “Cancer Breakthroughs” with AAPM, ASCO Research

The Imaging Technology News (ITN) editorial team is pleased to present the second portion of the American Society for ...

Time January 13, 2023
arrow
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James)
News | Proton Therapy
Leading U.S. Cancer Center Selects RayStation for Proton Planning

January 13, 2023 — RaySearch Laboratories AB announces that The Ohio State University Comprehensive Cancer Center - ...

Time January 13, 2023
arrow
RaySearch Laboratories AB announced that CGN Medical Technologies has in December 2002 placed an order for RayStation, which CGN has sold together with IBA’s proton therapy system to Yangzhou Hospital in China.
News | Proton Therapy
CGN Selects RayStation for Yangzhou Hospital

January 9, 2023 — RaySearch Laboratories AB announced that CGN Medical Technologies has in December 2002 placed an order ...

Time January 08, 2023
arrow
Top 20 for 2022
Feature | Radiology Business | By Melinda Taschetta-Millane
ITN's Top 20 from 2022

As 2022 comes to a close, the Imaging Technology News team takes a look at the year's most viewed content. Here is a ...

Time January 02, 2023
arrow
 IBA, a world leader in particle accelerator technology, today confirms that it has signed a contract with the Spanish Ministry of Health to install ten proton therapy systems across Spain as part of a significant public tender.
News | Proton Therapy
IBA Wins 10 Proton Therapy System Contract in Spain

January 2, 2023 — IBA, a world leader in particle accelerator technology, today confirms that it has signed a contract ...

Time January 02, 2023
arrow
Patients for Safer Nuclear Medicine calls NRC ruling a victory, notes work to protect patients is not over
News | Nuclear Imaging
Patient Coalition Applauds Federal Decision Impacting Nuclear Medicine Safety

January 2, 2023 — The federal agency that oversees the administration of nuclear medicine has announced that it will ...

Time January 02, 2023
arrow
The ITN team wishes you a happy and healthy New Year!
News | Imaging Technology News - ITN
Happy New Year from ITN

The ITN team wishes you a happy and healthy New Year!

Time January 01, 2023
arrow
New technology expected to drive efficiency with condensed treatment courses, fewer side effects, and improved outcomes for people with cancer
News | Linear Accelerators
First Ever Patient Treated for Pancreatic Cancer Using Elekta Unity MR-Linac

December 30, 2022 — A milestone was reached in radiation therapy last week as the first patients completed their full ...

Time December 30, 2022
arrow
December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines — such as doxorubicin, frequently used against breast cancer — kill cancer cells by damaging their DNA. However, these effective chemotherapies also cause toxic effects in the heart in about ten percent of patients that can eventually lead to heart failure, particularly in older patients with pre-existing cardiovascular disease. Current
News | Breast Imaging
Researchers ID Protein that may Protect the Heart During Certain Cancer Treatment Regimens

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including ...

Time December 29, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now